Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety and efficacy of a drug called
saxagliptin (Onglyza) for treatment of type 2 diabetes in non-critically ill hospitalized
patients who have an HbA1c of 7.5 or lower, on 1 or no non-insulin agent at home, or an HbA1c
≤7.0% on ≤ 2 non-insulin agents at home.